Functional analysis of the Mrg receptor family in pain sensation

Mrg受体家族在痛觉中的功能分析

基本信息

  • 批准号:
    7197537
  • 负责人:
  • 金额:
    $ 35.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-02-07 至 2011-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term objective of our research is to understand how pain-sensing neurons function at the molecular level under both normal conditions and chronic pain states. In mammals, the initial detection of pain stimuli is carried out by a group of sensory neurons, known as nociceptive neurons or pain-sensing neurons. Under chronic pain states, nociceptive neurons become hypersensitive to pain stimuli. Recently, we have identified a large family of G protein coupled receptors, called Mrgs, expressed specifically in pain-sensing neurons. We also found several RFamide peptides, including FMRFamide, gamma2-MSH and NPFF, acting as ligands for Mrgs in heterologous systems. Our electrophysiological studies indicate that FMRFamide can significantly increase excitability of nociceptive neurons in an Mrg-dependent manner. Our behavioral analysis showed that Mrg gene cluster knockout mice exhibit a prolonged inflammatory pain response as compared to wild-type mice. These data suggest that Mrgs play a modulatory role in pain. Here we propose to study the function of Mrgs in pain sensation further using Mrg knockout mice. Aim I is to analyze pain behavioral phenotypes in Mrg-deficient mice, from which we would like to determine whether Mrgs act to promote or reduce pain sensitivity in vivo and whether they play roles in chronic pain. In Aim II, we will characterize whether the injection of Mrg ligand peptides into wild-type mice can cause nociceptive effects. If they do, we will determine whether such effects are Mrg-dependent. Our recent data suggest that mast cells are likely to express the endogenous ligands for Mrgs. One promising candidate is the mammalian peptide NPFF. We will test whether mast cells express the peptide. If they do, we will check whether the degranulation of mast cells can release the peptide. We will also investigate Mrg receptor binding sites by autoradiography using radiolabeled NPFF and gamma2-MSH. Aim III is to study the molecular mechanisms of neuronal hyperexcitability induced by Mrg ligand peptides. Many ion channels have been implicated in regulating neuronal excitability of nociceptive neurons. We will employ electrophysiological recording techniques to determine whether Mrgs can modulate the activities of the ion channels in cultured DRG neurons. The proposed research will enhance our understanding of Mrg function in pain, which may allow the development of specific novel therapeutic agents for chronic pain with limited side effects.
描述(由申请人提供):我们研究的长期目标是了解在正常条件下和慢性疼痛状态下疼痛感受神经元在分子水平上的功能。在哺乳动物中,疼痛刺激的最初检测是由一组感觉神经元进行的,称为伤害感受神经元或疼痛感受神经元。在慢性疼痛状态下,伤害感受神经元对疼痛刺激变得超敏感。最近,我们已经确定了一个大家族的G蛋白偶联受体,称为Mrgs,表达特异性的疼痛感觉神经元。我们还发现了几种RFamide肽,包括FMRFamide,γ 2-MSH和NPFF,在异源系统中作为Mrgs的配体。我们的电生理学研究表明,FMRFamide可以显著增加伤害性神经元的兴奋性,在Mrg依赖的方式。我们的行为分析表明,Mrg基因簇敲除小鼠表现出较长的炎症疼痛反应相比,野生型小鼠。这些数据表明,Mrgs在疼痛中起着调节作用。在这里,我们建议进一步研究Mrg基因敲除小鼠在疼痛感觉中的功能。目的分析Mrg基因缺陷小鼠的疼痛行为表型,以确定Mrg基因在体内是否具有促进或降低疼痛敏感性的作用,以及是否在慢性疼痛中发挥作用。在目的II中,我们将表征Mrg配体肽注射到野生型小鼠中是否会引起伤害性效应。如果是这样,我们将确定这种效应是否依赖于Mrg。我们最近的数据表明,肥大细胞可能表达Mrgs的内源性配体。一个有希望的候选者是哺乳动物肽NPFF。我们将测试肥大细胞是否表达这种肽。如果是这样,我们将检查肥大细胞的脱粒是否可以释放肽。我们还将使用放射性标记的NPFF和γ 2-MSH通过放射自显影研究Mrg受体结合位点。目的III研究Mrg配体肽诱导神经元超兴奋的分子机制。许多离子通道参与了伤害感受神经元兴奋性的调节。我们将采用电生理记录技术,以确定是否Mrgs可以调节培养的DRG神经元的离子通道的活动。拟议的研究将增强我们对Mrg在疼痛中的功能的理解,这可能允许开发特定的新型治疗药物用于慢性疼痛,副作用有限。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xinzhong Dong其他文献

Xinzhong Dong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xinzhong Dong', 18)}}的其他基金

A Novel Mechanism of Mast Cell-Nerve Interactions in the Esophagus
食管肥大细胞与神经相互作用的新机制
  • 批准号:
    10475084
  • 财政年份:
    2020
  • 资助金额:
    $ 35.83万
  • 项目类别:
A Novel Mechanism of Mast Cell-Nerve Interactions in the Esophagus
食管肥大细胞与神经相互作用的新机制
  • 批准号:
    10266097
  • 财政年份:
    2020
  • 资助金额:
    $ 35.83万
  • 项目类别:
A Novel Mechanism of Mast Cell-Nerve Interactions in the Esophagus
食管肥大细胞与神经相互作用的新机制
  • 批准号:
    10093678
  • 财政年份:
    2020
  • 资助金额:
    $ 35.83万
  • 项目类别:
Characterization of a dendritic cell specific receptor critical for SJS
对 SJS 至关重要的树突状细胞特异性受体的表征
  • 批准号:
    9765148
  • 财政年份:
    2018
  • 资助金额:
    $ 35.83万
  • 项目类别:
Characterization of a dendritic cell specific receptor critical for SJS
对 SJS 至关重要的树突状细胞特异性受体的表征
  • 批准号:
    9982185
  • 财政年份:
    2018
  • 资助金额:
    $ 35.83万
  • 项目类别:
Characterization of a dendritic cell specific receptor critical for SJS
对 SJS 至关重要的树突状细胞特异性受体的表征
  • 批准号:
    10219058
  • 财政年份:
    2018
  • 资助金额:
    $ 35.83万
  • 项目类别:
A screen for small molecule modulators of human GPCR MrgX1
人 GPCR MrgX1 小分子调节剂的筛选
  • 批准号:
    8208371
  • 财政年份:
    2011
  • 资助金额:
    $ 35.83万
  • 项目类别:
A screen for small molecule modulators of human GPCR MrgX1
人 GPCR MrgX1 小分子调节剂的筛选
  • 批准号:
    8296486
  • 财政年份:
    2011
  • 资助金额:
    $ 35.83万
  • 项目类别:
Functional Analysis of Pirt and Pirt2: novel regulators of TRP channels
Pirt 和 Pirt2 的功能分析:TRP 通道的新型调节剂
  • 批准号:
    8118599
  • 财政年份:
    2010
  • 资助金额:
    $ 35.83万
  • 项目类别:
Functional Analysis of Pirt and Pirt2: novel regulators of TRP channels
Pirt 和 Pirt2 的功能分析:TRP 通道的新型调节剂
  • 批准号:
    7782647
  • 财政年份:
    2010
  • 资助金额:
    $ 35.83万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 35.83万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.83万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 35.83万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.83万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 35.83万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.83万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 35.83万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 35.83万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 35.83万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.83万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了